Arcadia Biosciences, Inc. Receives $1.99 Million Grant to Develop Reduced-Gluten Grains

Published: Oct 04, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, today announced that it has received an award from the U.S. National Institutes of Health’s (NIH) Diabetes and Digestive and Kidney Disorders Institute (NIDDK) to develop reduced-gluten grains. Under the award, which is expected to provide $1.99 million in funding, Arcadia’s internal research team will collaborate with Dr. Karol Sestak, Ph.D., associate professor of microbiology and immunology at Tulane University. This award builds on Arcadia’s previous NIH award focused on reducing gluten in grains, which was conducted in collaboration with Dr. Diter von Wettstein, the R.A. Nilan Distinguished Professor in the Department of Crop and Soil Sciences at Washington State University.

Help employers find you! Check out all the jobs and post your resume.

Back to news